KCTD4
gene geneOn this page
Also known as bA321C24.3
Summary
KCTD4 (potassium channel tetramerization domain containing 4, HGNC:23227) is a protein-coding gene on chromosome 13q14.12-q14.13, encoding BTB/POZ domain-containing protein KCTD4 (Q8WVF5).
Predicted to enable identical protein binding activity. Predicted to be involved in protein homooligomerization.
Source: NCBI Gene 386618 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_198404
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23227 |
| Approved symbol | KCTD4 |
| Name | potassium channel tetramerization domain containing 4 |
| Location | 13q14.12-q14.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA321C24.3 |
| Ensembl gene | ENSG00000180332 |
| Ensembl biotype | protein_coding |
| OMIM | 620638 |
| Entrez | 386618 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000379108
RefSeq mRNA: 1 — MANE Select: NM_198404
NM_198404
CCDS: CCDS9396
Canonical transcript exons
ENST00000379108 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001479791 | 45192853 | 45194754 |
| ENSE00003920564 | 45200824 | 45201045 |
Expression profiles
Bgee: expression breadth ubiquitous, 135 present calls, max score 93.13.
FANTOM5 (CAGE): breadth broad, TPM avg 1.8759 / max 271.3708, expressed in 351 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 137076 | 0.9352 | 170 |
| 137081 | 0.3283 | 148 |
| 137077 | 0.2336 | 91 |
| 137080 | 0.2038 | 97 |
| 137078 | 0.1003 | 46 |
| 207023 | 0.0439 | 9 |
| 137079 | 0.0308 | 11 |
Top tissues by expression
236 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 93.13 | gold quality |
| nucleus accumbens | UBERON:0001882 | 92.16 | gold quality |
| amygdala | UBERON:0001876 | 87.84 | gold quality |
| caudate nucleus | UBERON:0001873 | 86.51 | gold quality |
| temporal lobe | UBERON:0001871 | 84.42 | gold quality |
| cartilage tissue | UBERON:0002418 | 84.04 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 82.80 | gold quality |
| Ammon’s horn | UBERON:0001954 | 82.60 | gold quality |
| putamen | UBERON:0001874 | 82.27 | gold quality |
| entorhinal cortex | UBERON:0002728 | 80.80 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 79.92 | gold quality |
| endothelial cell | CL:0000115 | 79.37 | gold quality |
| prefrontal cortex | UBERON:0000451 | 79.13 | gold quality |
| corpus callosum | UBERON:0002336 | 78.70 | gold quality |
| amniotic fluid | UBERON:0000173 | 78.62 | gold quality |
| tibia | UBERON:0000979 | 78.55 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 78.24 | gold quality |
| forebrain | UBERON:0001890 | 77.26 | gold quality |
| hypothalamus | UBERON:0001898 | 76.84 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 76.77 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 76.31 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 76.06 | gold quality |
| cerebral cortex | UBERON:0000956 | 76.04 | gold quality |
| frontal cortex | UBERON:0001870 | 75.77 | gold quality |
| neocortex | UBERON:0001950 | 74.71 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 74.70 | gold quality |
| right frontal lobe | UBERON:0002810 | 74.62 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 73.85 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 73.36 | gold quality |
| tibial nerve | UBERON:0001323 | 73.28 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.12 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
99 targeting KCTD4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-6768-5P | 99.92 | 67.36 | 1942 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | kctd4 | ENSDARG00000068691 |
| mus_musculus | Kctd4 | ENSMUSG00000046523 |
| rattus_norvegicus | Kctd4 | ENSRNOG00000050996 |
| drosophila_melanogaster | twz | FBGN0034636 |
| caenorhabditis_elegans | F32B4.5 | WBGENE00009315 |
Paralogs (13): KCTD1 (ENSG00000134504), KCTD14 (ENSG00000151364), KCTD15 (ENSG00000153885), KCTD18 (ENSG00000155729), KCTD6 (ENSG00000168301), KCTD19 (ENSG00000168676), KCTD12 (ENSG00000178695), KCTD16 (ENSG00000183775), KCTD8 (ENSG00000183783), KCTD21 (ENSG00000188997), KCNRG (ENSG00000198553), KCTD11 (ENSG00000213859), KCTD7 (ENSG00000243335)
Protein
Protein identifiers
BTB/POZ domain-containing protein KCTD4 — Q8WVF5 (reviewed: Q8WVF5)
All UniProt accessions (1): Q8WVF5
RefSeq proteins (1): NP_940686* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR003131 | T1-type_BTB | Domain |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR045740 | KCTD4_C | Domain |
Pfam: PF02214, PF19323
UniProt features (4 total): chain 1, domain 1, region of interest 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WVF5-F1 | 81.52 | 0.50 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 94 (showing top):
FREAC3_01, RIGGI_EWING_SARCOMA_PROGENITOR_DN, NKX25_01, AACTTT_UNKNOWN, IK2_01, GOBP_PROTEIN_HOMOOLIGOMERIZATION, LEF1_Q6, WHN_B, AML1_01, FOX_Q2, chr13q14, YATGNWAAT_OCT_C, PR_01, KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN, MARTENS_TRETINOIN_RESPONSE_UP
GO Biological Process (1): protein homooligomerization (GO:0051260)
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein complex oligomerization | 1 |
| protein binding | 1 |
| binding | 1 |
Protein interactions and networks
STRING
478 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KCTD4 | CBY2 | Q8NA61 | 605 |
| KCTD4 | GTF2F2 | P13984 | 551 |
| KCTD4 | LDB2 | O43679 | 482 |
| KCTD4 | KCTD20 | Q7Z5Y7 | 466 |
| KCTD4 | GIGYF2 | Q6Y7W6 | 426 |
| KCTD4 | WDFY2 | Q96P53 | 412 |
| KCTD4 | TULP2 | O00295 | 402 |
| KCTD4 | PROSER2 | Q86WR7 | 401 |
| KCTD4 | KIAA1191 | Q96A73 | 394 |
| KCTD4 | BTBD19 | C9JJ37 | 389 |
| KCTD4 | FAM43B | Q6ZT52 | 359 |
| KCTD4 | BTBD10 | Q9BSF8 | 347 |
| KCTD4 | KLHL34 | Q8N239 | 340 |
| KCTD4 | HTR2A | P28223 | 339 |
| KCTD4 | GGA1 | Q9UJY5 | 339 |
IntAct
28 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EFHC1 | KCTD4 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TAE1 | KCTD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SRP1 | KCTD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KCTD4 | TAE1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KCTD4 | SRP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KCTD4 | DAXX | psi-mi:“MI:0915”(physical association) | 0.560 |
| KCTD4 | NTAQ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KCTD4 | KCTD4 | psi-mi:“MI:0915”(physical association) | 0.550 |
| KCTD4 | FER | psi-mi:“MI:0915”(physical association) | 0.490 |
| KCTD4 | TNS4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| FXR2 | KCTD4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| STX17 | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| OR2A4 | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| CCR1 | UBA6 | psi-mi:“MI:0914”(association) | 0.350 |
| DAXX | KCTD4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| EFHC1 | KCTD4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NTAQ1 | KCTD4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (16): KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Affinity Capture-Western), KCTD4 (Proximity Label-MS), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), DAXX (Two-hybrid), KCTD4 (Affinity Capture-MS), KCTD4 (Affinity Capture-MS)
ESM2 similar proteins: A1A5R8, A6H6X4, A9ULR9, B1WC97, B8JKF4, O15091, O70479, P93002, Q0VFV7, Q12259, Q13829, Q28DC9, Q2HJ48, Q2T9W0, Q3TUL7, Q3URF8, Q4G0X4, Q5EAX2, Q5F3E8, Q5H9S7, Q5M956, Q5R4M2, Q5RBH4, Q5RD58, Q5XJ34, Q5ZJP7, Q68FF0, Q6DC02, Q6DCX3, Q6DFW0, Q6DG99, Q6NSI8, Q6P3P4, Q719H9, Q7TNY1, Q7TPL3, Q8BJK1, Q8BNL5, Q8NC69, Q8R4G8
Diamond homologs: A3KMV1, A4IFB4, A5PKG7, A6H6X4, B1WC97, B5DEL1, D5SHR0, G5EFC3, O65555, P0C5J9, P15388, P17971, P17972, P25122, P48547, P59994, P59995, Q01956, Q03607, Q03719, Q0VD00, Q0VFV7, Q14003, Q14681, Q29RJ0, Q2HJ48, Q2TUM3, Q3URF8, Q4G0X4, Q50H33, Q52PG9, Q54KH0, Q5DTY9, Q5M956, Q5XJ34, Q5ZJP7, Q62897, Q63881, Q63959, Q68DU8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
211 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 13:45199942:G:GT | donor_gain | 0.9700 |
| 13:45194395:A:T | donor_gain | 0.8500 |
| 13:45195339:A:AC | acceptor_gain | 0.8200 |
| 13:45193040:G:GA | donor_gain | 0.8000 |
| 13:45195336:CTTA:C | acceptor_gain | 0.7900 |
| 13:45195340:A:G | acceptor_gain | 0.7900 |
| 13:45193062:ACCT:A | donor_gain | 0.7400 |
| 13:45194719:G:GG | donor_gain | 0.7400 |
| 13:45199964:GA:G | donor_gain | 0.7400 |
| 13:45194718:A:AG | donor_gain | 0.7100 |
| 13:45198780:T:G | acceptor_gain | 0.7000 |
| 13:45199953:G:GA | donor_gain | 0.6800 |
| 13:45194560:C:CA | acceptor_gain | 0.6700 |
| 13:45194760:G:GG | donor_gain | 0.6600 |
| 13:45197974:C:T | donor_gain | 0.6500 |
| 13:45194759:A:AG | donor_gain | 0.6400 |
| 13:45193038:GTG:G | donor_gain | 0.6300 |
| 13:45193037:AGT:A | donor_gain | 0.6200 |
| 13:45200408:A:AG | donor_gain | 0.6100 |
| 13:45194799:G:T | donor_gain | 0.6000 |
| 13:45194415:C:A | donor_gain | 0.5900 |
| 13:45193044:CT:C | donor_gain | 0.5800 |
| 13:45195430:ACTGT:A | donor_gain | 0.5600 |
| 13:45195469:GGAGA:G | donor_gain | 0.5600 |
| 13:45193933:T:TA | donor_gain | 0.5500 |
| 13:45195338:TA:T | acceptor_gain | 0.5500 |
| 13:45195342:A:G | acceptor_gain | 0.5500 |
| 13:45193036:AAGT:A | donor_gain | 0.5400 |
| 13:45195466:ATAGG:A | donor_gain | 0.5400 |
| 13:45193375:A:C | acceptor_gain | 0.5300 |
AlphaMissense
1711 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 13:45194091:A:C | C159W | 0.999 |
| 13:45194287:C:G | R94P | 0.999 |
| 13:45194299:A:G | L90P | 0.999 |
| 13:45193900:A:G | L223P | 0.998 |
| 13:45193916:A:G | C218R | 0.998 |
| 13:45193945:A:G | L208P | 0.998 |
| 13:45194056:C:G | R171P | 0.998 |
| 13:45194092:C:T | C159Y | 0.998 |
| 13:45194093:A:G | C159R | 0.998 |
| 13:45194228:C:G | A114P | 0.998 |
| 13:45194290:A:G | L93P | 0.998 |
| 13:45194311:A:G | F86S | 0.998 |
| 13:45194320:C:T | G83D | 0.998 |
| 13:45194323:T:A | D82V | 0.998 |
| 13:45194326:C:A | R81M | 0.998 |
| 13:45194438:A:C | Y44D | 0.998 |
| 13:45194449:C:A | G40V | 0.998 |
| 13:45193798:A:G | F257S | 0.997 |
| 13:45193804:A:G | L255P | 0.997 |
| 13:45193876:G:T | A231D | 0.997 |
| 13:45193889:C:G | A227P | 0.997 |
| 13:45193914:A:C | C218W | 0.997 |
| 13:45193920:A:C | F216L | 0.997 |
| 13:45193920:A:T | F216L | 0.997 |
| 13:45193922:A:G | F216L | 0.997 |
| 13:45193939:A:G | L210P | 0.997 |
| 13:45193981:A:G | F196S | 0.997 |
| 13:45194239:A:G | L110P | 0.997 |
| 13:45194324:C:G | D82H | 0.997 |
| 13:45194452:A:T | V39D | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000462647 (13:45199469 T>C), RS1001075032 (13:45192399 G>C), RS1001378215 (13:45199502 A>C), RS1001403268 (13:45200379 T>C), RS1001434546 (13:45200176 G>A), RS1002047937 (13:45198927 A>G), RS1002503118 (13:45202663 G>A), RS1002601325 (13:45202923 A>G), RS1002637628 (13:45193686 G>A,C), RS1003092459 (13:45196034 A>G,T), RS1003677370 (13:45195166 A>G), RS1003748215 (13:45201769 G>A), RS1003780867 (13:45201553 A>G), RS1004022988 (13:45198406 C>A), RS1004121315 (13:45198845 G>T)
Disease associations
OMIM: gene MIM:620638 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Nickel | decreases expression | 2 |
| nickel sulfate | decreases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Silicon Dioxide | affects expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Vanadates | increases expression | 1 |
| Asbestos, Crocidolite | affects methylation | 1 |
| Lactic Acid | decreases expression | 1 |
| Magnetite Nanoparticles | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.